HM Nou Delfos Hospital provides advanced chemotherapy for prostate cancer within Spain's largest private hospital network, HM Hospitals. Dr. Begoña Mellado González, a senior urological oncology consultant at Hospital Clínic de Barcelona, oversees prostate cancer care at HM Delfos with a translational research background from Memorial Sloan-Kettering Cancer Center. Her team coordinates multidisciplinary treatment plans and clinical trial access. The facility features dedicated oncology units with the latest diagnostic and therapeutic technologies including CT and MRI for tumor monitoring. Dr. Mellado has published 140+ scientific articles and leads research on prostate cancer treatment resistance biomarkers.